Celon Pharma SA's market cap is currently zł1.23B. The company's EPS TTM is zł-0.617; its P/E ratio is 74.93; and it has a dividend yield of 0.35%. Celon Pharma SA is scheduled to report earnings on September 17, 2025, and the estimated EPS forecast is zł―. See an overview of income statement, balance sheet, and cash flow financials.
